Nuix FY26 slides: Neo platform drives 179% ACV surge, profit jumps 60%

Nuix (ASX:NXL) reported fiscal 2026 results with ACV of $260.0M (+13.9% YoY) and adjusted management EBITDA up 60.4% to $59.8M, driving an 18.6% share price jump to $1.69. Revenue rose 18.8% to $263.2M and adjusted EBITDA margin expanded 590bps to 22.7%, while cash generation surged with underlying cash flow up 154% to $51.0M and free cash flow up 831% to $37.4M (85% conversion). Nuix Neo is the primary growth driver, with ACV up 179% to $78.5M (30% of total ACV) and a planned “Phase 3: Execution at Scale” through fiscal 2030; fiscal 2027 ACV guidance is $285–$300M (+9.6% to +15.4%) with EBITDA expected similar to $59.8M after a one-off $15M R&D Accelerator.

Analysis

Nuix is transitioning from a niche recovery story to a genuine operating-leverage story, but the second-order implication is that the stock is now being priced on migration durability, not just current ACV growth. The main winner is Nuix itself if Neo can keep taking share in regulated workflows; the main loser is its legacy component base, which is effectively a cannibalization pool that should keep elevating mix and gross margin if execution holds. That said, the competitive set will not stand still: point solutions in e-discovery, legal review, and graph analytics can undercut on price if Nuix’s platform premium is not clearly tied to measurable workflow savings.

The near-term catalyst path is less about the print and more about whether the next 1-2 quarters confirm that Neo is becoming the default sales motion. The market will likely look through the one-off accelerator spend only if bookings cadence and cash conversion remain intact; if not, FY27 looks like a reset year with EBITDA held flat despite incremental investment. Key falsifiers are a drop in renewal quality, a reacceleration of churn above the mid-single digits, or any evidence that the reported growth is being pulled forward via aggressive contract terms rather than durable adoption.

Contrarian view: the move may be partially overdone because the market is extrapolating a small-base migration into a long-duration secular win. Neo’s growth is impressive, but the moat is more governance and switching friction than pure AI differentiation, so valuation should be capped until the company proves repeatable net-new wins outside the installed base. The better asymmetry is likely in waiting for a post-earnings pullback or pairing Nuix against a slower-moving enterprise software name where cash flow is weaker and the re-rate is less justified.

Key Decisions for Investors

• Add NXLLF only on a 5-8% pullback from the post-results spike; the trade is a 3-6 month rerate toward cash-flow quality, with a stop if Neo growth or FCF conversion deteriorates in the next update.
• Set a catalyst watch for FY27 quarterly ACV and NDR: if NDR holds above ~105% and churn stays near current levels, keep the long; if retention slips, fade the rally aggressively.
• Relative-value idea: long NXLLF vs short OTEX over 1-3 months. Thesis: Nuix has cleaner operating leverage and a more visible platform migration, while the short side faces slower organic growth and lower incremental margin capture.
• Do not chase calls here; if anything, use a covered-call approach into the next print only if you already own the equity, because the stock is likely to digest the gain while the market waits for proof of FY27 execution.